Skip to Content

News

Nanobodies: going single domain

Conventional antibodies are not suitable for in vivo studies, which has limited some applications in basic research, therapeutics, and diagnostics. Andrew Wiecek investigates how camel, llama, and shark antibodies are being used to overcome this limitation.

Study finds how nanoparticles indirectly damage DNA in cells

British researchers who built a multi-layer "barrier" of human cells to replicate the function of specialized protective tissues in the body found that signals transmitted by nanoparticles through the protective barrier indirectly damage DNA inside cells. The study results "expand significantly the hurdles that any theoretical nano-safety assessment would need to clear," an expert said. The discovered mechanism, however, also opens up the possibility of being able to deliver treatments across barriers without actually crossing them, another expert suggested.

Canary Funds Early Cancer Center at Stanford

NEW YORK (GenomeWeb News) – Stanford University will use a $15 million commitment from the Canary Foundation, along with $5 million of its own funds, to start a cancer research center focused on using proteomics and imaging techniques to find ways to identify cancer earlier.

Preclinical Drug Development Must Consider the Impact on Metastasis

Drs. Steeg et al., President and members of the "Metastasis Research Society " propose that preclinical anticancer drug development be required to show efficacy in at least one metastasis model, preferably incorporating metastasis from an orthotopic site.  Robust models are available with relevant histology and Imaging for quantification.

 

Clin Cancer Res 2009; 15 (14) July 15, 2009

Infrared-fluorescent proteins for whole body imaging

2008 Nobel-Prize winner Roger Tsien, Ph.D., has engineered infrared-fluorescent proteins (IFPs) that are are suitable for whole-body imaging in small animals.

The 2009 Lindau Nobel Laureate Meeting: Roger Y. Tsien, Chemistry 2008 (Jove video)